Pulmagen Therapeutics

Pulmagen’s clinical and preclinical pipeline of therapies for chronic respiratory diseases such as COPD, asthma and cystic fibrosis delivers both symptomatic relief (bronchodilators) and a disease modifying effect (anti-inflammatory).